ibuzatrelvir

N/A

Report date: 2026/05/16 20:00:17
NME

Base Information

Drug Nameibuzatrelvir
Drug Alias NameKZ2X7QH2VTPF-07817883PF-7817883
ClassificationSmall molecules > Heterocyclic drugs
Mechanisms of ActionSARS-CoV-2-3C-like-proteinase inhibitors
TargetsSARS-CoV-2-3C-like-proteinase
Therapy Area/IndicationsCoronavirus Disease 2019 (COVID-19)Lung DiseasesRespiratory Tract Diseases +[5] 
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryCzechiaBelgiumBulgaria +[24] 
CombinationsNo
Global Highest StatusPhase 3 Clinical
Highest Status in ChinaPhase 3 Clinical
Originator CompaniesPfizer Inc
China Registration ClassN/A

Develop Information

Active CompaniesPfizer (China) Research And Development Co LtdPfizer Inc
Inactive CompaniesN/A
Active IndicationsCoronavirus Disease 2019 (COVID-19)Lung DiseasesPneumonia +[4] 
Inactive IndicationsRespiratory Tract Diseases

Other Information

ATC CodeN/A
Related LinksKEGG